252 related articles for article (PubMed ID: 17137605)
21. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis.
Aoyama I; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S8-14. PubMed ID: 12612943
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of angiogenic factors and their downstream target molecules affects the deterioration of erectile function in a rat model of hypercholesterolemia.
Ryu JK; Shin HY; Song SU; Oh SM; Piao S; Han JY; Park KW; Suh JK
Urology; 2006 Jun; 67(6):1329-34. PubMed ID: 16750245
[TBL] [Abstract][Full Text] [Related]
23. D-Serine exposure resulted in gene expression changes implicated in neurodegenerative disorders and neuronal dysfunction in male Fischer 344 rats.
Davidson ME; Kerepesi LA; Soto A; Chan VT
Arch Toxicol; 2009 Aug; 83(8):747-62. PubMed ID: 19212759
[TBL] [Abstract][Full Text] [Related]
24. Localization of increased insulin-like growth factor binding protein-3 in diabetic rat penis: implications for erectile dysfunction.
Soh J; Katsuyama M; Ushijima S; Mizutani Y; Kawauchi A; Yabe-Nishimura C; Miki T
Urology; 2007 Nov; 70(5):1019-23. PubMed ID: 18068478
[TBL] [Abstract][Full Text] [Related]
25. Whole genome microarray of the major pelvic ganglion after cavernous nerve injury: new insights into molecular profile changes after nerve injury.
Calenda G; Strong TD; Pavlovich CP; Schaeffer EM; Burnett AL; Yu W; Davies KP; Bivalacqua TJ
BJU Int; 2012 May; 109(10):1552-64. PubMed ID: 22300381
[TBL] [Abstract][Full Text] [Related]
26. Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic rats.
De Young LX; Domes T; Lim K; Carson J; Brock GB
Eur Urol; 2008 Jul; 54(1):213-20. PubMed ID: 18342431
[TBL] [Abstract][Full Text] [Related]
27. Analysis of gene expression profiles in the offspring of rats following maternal exposure to xenoestrogens.
Dang VH; Choi KC; Hyun SH; Jeung EB
Reprod Toxicol; 2007 Jan; 23(1):42-54. PubMed ID: 17011747
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum.
Toque HA; Teixeira CE; Lorenzetti R; Okuyama CE; Antunes E; De Nucci G
Eur J Pharmacol; 2008 Sep; 591(1-3):189-95. PubMed ID: 18593576
[TBL] [Abstract][Full Text] [Related]
29. Effects of 3-methylcholanthrene on gene expression profiling in the rat using cDNA microarray analyses.
Kondraganti SR; Muthiah K; Jiang W; Barrios R; Moorthy B
Chem Res Toxicol; 2005 Nov; 18(11):1634-41. PubMed ID: 16300371
[TBL] [Abstract][Full Text] [Related]
30. [Phosphodiesterase type 5 siRNA increases cGMP in the smooth muscle cells of human corpus cavernosum].
Chen GQ; Bai WJ; Wang XF; Liu SJ; He PY; Hou SK
Zhonghua Nan Ke Xue; 2006 Nov; 12(11):979-81, 984. PubMed ID: 17146920
[TBL] [Abstract][Full Text] [Related]
31. Expression of myosin isoforms in the smooth muscle of human corpus cavernosum.
Koi PT; Milhoua PM; Monrose V; Melman A; DiSanto ME
Int J Impot Res; 2007; 19(1):62-8. PubMed ID: 16885993
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol diet-induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microarray study.
Puskás LG; Nagy ZB; Giricz Z; Onody A; Csonka C; Kitajka K; Hackler L; Zvara A; Ferdinandy P
FEBS Lett; 2004 Mar; 562(1-3):99-104. PubMed ID: 15044008
[TBL] [Abstract][Full Text] [Related]
33. Substituted pyrazolopyridopyridazines as orally bioavailable potent and selective PDE5 inhibitors: potential agents for treatment of erectile dysfunction.
Yu G; Mason H; Wu X; Wang J; Chong S; Beyer B; Henwood A; Pongrac R; Seliger L; He B; Normandin D; Ferrer P; Zhang R; Adam L; Humphrey WG; Krupinski J; Macor JE
J Med Chem; 2003 Feb; 46(4):457-60. PubMed ID: 12570368
[TBL] [Abstract][Full Text] [Related]
34. Direct androgen regulation of PDE5 gene or the lack thereof.
Lin CS; Xin Z; Namiki M; Albersen M; Muller D; Lue TF
Int J Impot Res; 2013 May; 25(3):81-5. PubMed ID: 23486196
[TBL] [Abstract][Full Text] [Related]
35. Optimisation of PDE5 inhibitor therapy in men with erectile dysfunction: converting "non-responders" into "responders".
Eardley I
Eur Urol; 2006 Jul; 50(1):31-3. PubMed ID: 16517052
[No Abstract] [Full Text] [Related]
36. [Gene expression profile in acute spinal cord injury screened by cDNA microarray: experiment with rats].
Dong DM; Yao M; Li KS; Wang YS
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2495-501. PubMed ID: 17156681
[TBL] [Abstract][Full Text] [Related]
37. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia.
Gholami SS; Rogers R; Chang J; Ho HC; Grazziottin T; Lin CS; Lue TF
J Urol; 2003 Apr; 169(4):1577-81. PubMed ID: 12629419
[TBL] [Abstract][Full Text] [Related]
38. Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters.
Lin CS; Chow S; Lau A; Tu R; Lue TF
Int J Impot Res; 2002 Feb; 14(1):15-24. PubMed ID: 11896473
[TBL] [Abstract][Full Text] [Related]
39. Effect of udenafil on portal venous pressure and hepatic fibrosis in rats. A novel therapeutic option for portal hypertension.
Choi SM; Shin JH; Kim JM; Lee CH; Kang KK; Ahn BO; Yoo M
Arzneimittelforschung; 2009; 59(12):641-6. PubMed ID: 20108650
[TBL] [Abstract][Full Text] [Related]
40. Chronic treatment with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of diabetic erectile dysfunction.
Park K; Ryu KS; Li WJ; Kim SW; Paick JS
Eur Urol; 2008 Jun; 53(6):1282-8. PubMed ID: 18243503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
